Relay Therapeutics, Inc.
Status: Publicly traded
Direct answer
Relay Therapeutics, Inc. is publicly traded on NASDAQ under the ticker RLAY.
Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions. The company's pipeline features several promising drug candidates: RLY-4008, an orally administered small molecule...
Can you invest in Relay Therapeutics, Inc.?
Yes. Relay Therapeutics, Inc. trades publicly on NASDAQ as RLAY.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Relay Therapeutics, Inc.
Detailed equity research is provided by MarketSnap.